Although the role of androgen/AR signaling in lymphocytes in breast cancer is not yet well understood, recent research by Li et al. investigated the relationship between immune checkpoint receptor expression on T cells in breast cancer tissues and androgen levels in the serum of breast cancer patients [138]. The gene discussed is AR; the disease is breast cancer.